Eric Hampton

3.1k total citations
17 papers, 1.5k citations indexed

About

Eric Hampton is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Eric Hampton has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Biomedical Engineering. Recurrent topics in Eric Hampton's work include CAR-T cell therapy research (8 papers), Nanowire Synthesis and Applications (5 papers) and Virus-based gene therapy research (3 papers). Eric Hampton is often cited by papers focused on CAR-T cell therapy research (8 papers), Nanowire Synthesis and Applications (5 papers) and Virus-based gene therapy research (3 papers). Eric Hampton collaborates with scholars based in United States, South Korea and Australia. Eric Hampton's co-authors include Travis S. Young, Cristina Godio, Nico Mitro, Valentina Molteni, Enrique Sáez, Andreas Kreusch, Puiying A. Mak, David T. Rodgers, Scott A. Lesley and Peter G. Schultz and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition.

In The Last Decade

Eric Hampton

17 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Hampton United States 13 752 625 444 342 277 17 1.5k
Nayiyuan Wu China 24 742 1.0× 1.7k 2.8× 120 0.3× 123 0.4× 426 1.5× 84 2.9k
Lawrence A. Vernetti United States 22 237 0.3× 778 1.2× 245 0.6× 766 2.2× 66 0.2× 40 1.7k
Tomasz Cichoń Poland 19 378 0.5× 698 1.1× 118 0.3× 209 0.6× 348 1.3× 58 1.4k
Dong Yang China 19 553 0.7× 503 0.8× 42 0.1× 75 0.2× 328 1.2× 53 1.2k
Klaus Wielckens Germany 21 560 0.7× 702 1.1× 83 0.2× 47 0.1× 239 0.9× 51 1.4k
Dinglan Wu China 23 279 0.4× 636 1.0× 65 0.1× 90 0.3× 116 0.4× 44 1.1k
Daqing Wu United States 24 460 0.6× 942 1.5× 104 0.2× 56 0.2× 167 0.6× 56 1.7k
William D. Stuart United States 21 677 0.9× 692 1.1× 236 0.5× 22 0.1× 334 1.2× 51 1.6k
Lijun Di China 25 602 0.8× 1.0k 1.7× 81 0.2× 73 0.2× 236 0.9× 102 1.9k
Shou‐Ching Tang United States 24 542 0.7× 1.3k 2.0× 70 0.2× 52 0.2× 175 0.6× 85 1.8k

Countries citing papers authored by Eric Hampton

Since Specialization
Citations

This map shows the geographic impact of Eric Hampton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Hampton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Hampton more than expected).

Fields of papers citing papers by Eric Hampton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Hampton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Hampton. The network helps show where Eric Hampton may publish in the future.

Co-authorship network of co-authors of Eric Hampton

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Hampton. A scholar is included among the top collaborators of Eric Hampton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Hampton. Eric Hampton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kitamura, Seiya, Natalia Milosevich, Joshua N. Asiaban, et al.. (2021). Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia. ACS Central Science. 7(5). 815–830. 63 indexed citations
2.
Hampton, Eric, et al.. (2021). JAML promotes CD8 and γδ T cell antitumor immunity and is a novel target for cancer immunotherapy. The Journal of Experimental Medicine. 218(10). 22 indexed citations
3.
Asiaban, Joshua N., Natalia Milosevich, Emily Chen, et al.. (2020). Cell-Based Ligand Discovery for the ENL YEATS Domain. ACS Chemical Biology. 15(4). 895–903. 26 indexed citations
4.
Raj, Deepak B. Thimiri Govinda, Ming-Hsin Yang, David T. Rodgers, et al.. (2018). Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma. Gut. 68(6). 1052–1064. 116 indexed citations
5.
Viaud, Sophie, S. Y. Jennifer, Ian R. Hardy, et al.. (2018). Switchable control over in vivo CAR T expansion, B cell depletion, and induction of memory. Proceedings of the National Academy of Sciences. 115(46). E10898–E10906. 73 indexed citations
6.
Hampton, Eric, et al.. (2017). A Novel Switchable CAR-T Platform for Acute Lymphoblastic Leukemia Treatment. Blood. 130. 3890–3890. 2 indexed citations
7.
Yu, Shan, Reyna K. V. Lim, David T. Rodgers, et al.. (2017). P-262 A PDE4 Inhibitor-antibody Conjugate for Treating Ulcerative Colitis. Inflammatory Bowel Diseases. 23. 1 indexed citations
8.
Mazagova, Magdalena, Sida Shao, Xinxin Wang, et al.. (2017). Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia. International Journal of Molecular Sciences. 18(11). 2259–2259. 58 indexed citations
9.
Cao, Yu, David T. Rodgers, Juanjuan Du, et al.. (2016). Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer. Angewandte Chemie International Edition. 55(26). 7520–7524. 103 indexed citations
10.
Rodgers, David T., Magdalena Mazagova, Eric Hampton, et al.. (2016). Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies. Proceedings of the National Academy of Sciences. 113(4). E459–68. 317 indexed citations
11.
Yu, Shan, Reyna K. V. Lim, David T. Rodgers, et al.. (2016). Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody–drug Conjugate. Molecular Therapy. 24(12). 2078–2089. 41 indexed citations
12.
Cao, Yu, David T. Rodgers, Juanjuan Du, et al.. (2016). Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer. Angewandte Chemie. 128(26). 7646–7650. 8 indexed citations
13.
Johnson, Hope A., Eric Hampton, & Scott A. Lesley. (2009). The Thermotoga maritima Trk Potassium Transporter—from Frameshift to Function. Journal of Bacteriology. 191(7). 2276–2284. 12 indexed citations
14.
Hu, Huiyong, Heath E. Klock, Eric Hampton, et al.. (2009). Time-resolved fluorescence resonance energy transfer and surface plasmon resonance-based assays for retinoid and transthyretin binding to retinol-binding protein 4. Analytical Biochemistry. 392(2). 162–168. 6 indexed citations
15.
Hampton, Eric, Mark W. Knuth, Jun Li, et al.. (2007). The self-inhibited structure of full-length PCSK9 at 1.9 Å reveals structural homology with resistin within the C-terminal domain. Proceedings of the National Academy of Sciences. 104(37). 14604–14609. 122 indexed citations
16.
Li­, ­Jun, Christine Tumanut, Julie-Ann Gavigan, et al.. (2007). Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity. Biochemical Journal. 406(2). 203–207. 128 indexed citations
17.
Mitro, Nico, Puiying A. Mak, Cristina Godio, et al.. (2006). The nuclear receptor LXR is a glucose sensor. Nature. 445(7124). 219–223. 427 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026